Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T13:09:29.092Z Has data issue: false hasContentIssue false

2 - Making hybridomas (hybridoma technology)

Published online by Cambridge University Press:  23 November 2009

Get access

Summary

Chapter 1 described the interactions and communications which occur during an immune response against non-self material (antigen). From this, it can be seen how hybrid cell lines could be produced which would secrete antibody reactive against a particular antigen. In this chapter, the requirements for the production of such hybrid cell lines–hybridomas – will be explained. The two major factors involved are the use of a tissue-culture-adapted lymphoblastoid cell line (myeloma cell line) and antigen-stimulated (in vivo or in vitro)lymphocytes. The characteristics and production of myeloma cells will be described; details of how these cells play a major role both in the production of hybridomas, through chemical-induced fusion with the antigen-stimulated lymphocytes, and in subsequent stabilisation of the hybrid cells in vitro will be presented. Procedural requirements for generating antigen-stimulated lymphocytes which are to be used in hybridoma production will be explained; and §2.6 will present a practical guide to the preparation of the myeloma cells and lymphocytes, fusion to produce hybridomas and selection of myeloma cell-lymphocyte hybrid cells. Since this book is concerned with antibody-secreting hybridomas, most of the details will be concerned with these; but reference will be made to other types of lymphocyte derived hybrid cell lines, in particular in §2.7.

Basic requirements

The basic constituents of any hybridoma or hybrid cell line are the parent cells required for its formation.With the immune B cell hybridomas (which secrete antibody) these parents are splenocytes from the appropriate animal immunised with the antigen of choice, and tissue-culture adapted myeloma cells (1–6).

Type
Chapter
Information
Monoclonal Antibodies in Biotechnology
Theoretical and Practical Aspects
, pp. 90 - 137
Publisher: Cambridge University Press
Print publication year: 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×